Pertuzumab (P) + trastuzumab (T) with or without chemotherapy both followed by T-DM1 in case of progression in patients with HER2-positive metastatic breast cancer (MBC) - The PERN... von Huober, J., Ribi, K., Weder, P., Li, Q., Vanlemmens, L., Gerard, M.-A., Lemonnier, J., Thürlimann, B., Boven, E., Bonnefoi, H.

Volltext

PERNETTA: A non-comparative randomized open label phase II trial of pertuzumab (P) + trastuzumab (T) with or without chemotherapy both followed by T-DM1 in case of progression, in... von Huober, J., Weder, P., Veyret, C., Thürlimann, B., Xyrafas, A., Vanlemmens, L., Guiu, S., Brain, E., Grenier, J., Dalenc, F., Levy, C., Savoye, A.M., Müller, A., Membrez-Antonioli, V., Gerard, M.A., Lemonnier, J., Hawle, H., Boven, E., Bonnefoi, H.

Volltext

EP-0999: Re-irradiation ± bevacizumab in recurrent or progressive HGG: retrospective analysis of 13 patients von Brügge, D, Plasswilm, L, Hundsberger, T, Weder, P

Volltext

Expression of Methylthioadenosine Phosphorylase (MTAP) in Pilocytic Astrocytomas von Becker, Aline Paixão, Scapulatempo-Neto, Cristovam, Menezes, Weder P., Clara, Carlos, Machado, Hélio R., Oliveira, Ricardo S., Neder, Luciano, Reis, Rui Manuel

Volltext

Loss of MTAP expression is a negative prognostic marker in Ewing sarcoma family of tumors von Abrahao-Machado, Lucas Faria, Antunes, Bruno, Filippi, Renee Zon, Volc, Sahlua, Boldrini, Erica, Menezes, Weder P, Reis, Rui M, de Camargo, Olavo Pires

Volltext

Melanoma-specific tumor-infiltrating lymphocytes but not circulating melanoma-specific T cells may predict survival in resected advanced-stage melanoma patients von HAANEN, J. B. A. G, BAARS, A, PINEDO, H. M, VAN DEN EERTWEGH, A. J. M, GOMEZ, R, WEDER, P, SMITS, M, DE GRUIJL, T. D, VON BLOMBERG, B. M. E, BLOEMENA, E, SCHEPER, R. J, VAN HAM, S. M

Volltext

Identification of Plant Food Raw Material by RAPD-PCR:  Legumes von Weder, Jürgen K. P

Volltext

306P Multiplexed immunofluorescence (mIF) to select patients with HER2+ breast cancer (BC) having an excellent outcome without chemotherapy (chemo): A substudy of the PERNETTA tria... von Zaman, K., Tissot, S., Benedetti, F., Dietrich, D., Tarussio, D., Huober, J., Bonnefoi, H., Weder, P., Boven, E., Rusakiewicz, S., Kandalaft, L.E.

Volltext

Survival after neoadjuvant chemotherapy with or without bevacizumab or everolimus for HER2-negative primary breast cancer (GBG 44–GeparQuinto) von von Minckwitz, G., Fasching, P.A., Schrader, I., Kittel, K., Huober, J., Solbach, C., Jackisch, C., Blohmer, J.U., Nekljudova, V., Gerber, B., Groh, U., Villena, C., Liedtke, B., Kittel, K., Mau, C., Potenberg, J., Schilling, J., Just, M., Bückner, U., Doering, G., Feidicker, S., Krabisch, P., Augustin, D., Nestle-Krämling, C., Rezai, M., Höß, C., Terhaag, J., Fasching, P., Staib, P., Aktas, B., Kühn, T., Khandan, F., Möbus, V., Solbach, C., Tesch, H., Stickeler, E., Heinrich, G., Wagner, H., Abdallah, A., Dewitz, T., Emons, G., Belau, A., Rethwisch, V., Lantzsch, T., Müller, V., Holms, F., Müller, T., Deuker, J.-U., Solomayer, E., Runnebaum, I., Link, H., Conrad, B., Feisel-Schwickardi, G., Steinmetz, T., Langanke, D., Ober, A., Fischer, D., Kohls, A., Weikel, W., Bischoff, J., Freese, K., Wiest, W., Sütterlin, M., Dietrich, M., Grießhammer, M., Burgmann, D.-M., Hanusch, C., Rack, B., Salat, C., Sattler, D., Tio, J., Christensen, B., Burkamp, U., Köhne, C.-H., Meinerz, W., Graßhoff, S.-T., Decker, T., Thalmann, I., Sallmann, A., Beck, T., Reimer, T., Bartzke, G., Deryal, M., Weigel, M., Huober, J., Steffens, C.-C., Lemster, S., Stefek, A., Ruhland, F., Hofmann, M., Schuster, J., Clemens, M., Fehm, T., Janni, W., Latos, K., Bauer, W., Roßmann, A., Bauer, L., Hoffmann, G., Schlag, R.

Volltext

Enhancement of LFA-1-mediated cell adhesion by triggering through CD2 or CD3 on T lymphocytes von van Kooyk, Y, van de Wiel-van Kemenade, P, Weder, P, Kuijpers, T. W, Figdor, C. G

Volltext

150O_PRPertuzumab (P) + trastuzumab (T) with or without chemotherapy both followed by T-DM1 in case of progression in patients with HER2-positive metastatic breast cancer (MBC) - T... von Huober, J, Ribi, K, Weder, P, Li, Q, Vanlemmens, L, Gerard, M-A, Lemonnier, J, Thürlimann, B, Boven, E, Bonnefoi, H

Volltext

Familial Cutaneous Mycosis fungoides: Successful Treatment with a Combination of Gemcitabine and Alemtuzumab von Weder, P., Anliker, M., Itin, P., Bargetzi, M.

Volltext

Complete Amino Acid Sequence of the Lentil Trypsin−Chymotrypsin Inhibitor LCI-1.7 and a Discussion of Atypical Binding Sites of Bowman−Birk Inhibitors von Weder, Jürgen K. P, Hinkers, Sabine C

Volltext

288PDPERNETTA: A non-comparative randomized open label phase II trial of pertuzumab (P) + trastuzumab (T) with or without chemotherapy both followed by T-DM1 in case of progression... von Huober, J, Weder, P, Veyret, C, Thürlimann, B, Xyrafas, A, Vanlemmens, L, Guiu, S, Brain, E, Grenier, J, Dalenc, F, Levy, C, Savoye, A M, Müller, A, Membrez-Antonioli, V, Gerard, M A, Lemonnier, J, Hawle, H, Boven, E, Bonnefoi, H

Volltext

Reaction of Lentil Trypsin−Chymotrypsin Inhibitors with Human and Bovine Proteinases von Weder, Jürgen K. P, Kahleyss, Ralf

Volltext

Long-term responders to trastuzumab monotherapy in the first-line metastatic setting: characteristics and survival data (SAKK 22/99 Trial) von Schmid, S., Klingbiel, D., Goldhirsch, A., Oehlschlegel, C., Munzone, E., Nolè, F., Pestalozzi, B., Aebi, S., Rochlitz, C., von Moos, R., Zaman, K., Mamot, C., Weder, P., Thuerlimann, B., Pagani, O., Ruhstaller, T.

Volltext

Copy Number Profiling of Brazilian Astrocytomas von Bidinotto, Lucas Tadeu, Torrieri, Raul, Mackay, Alan, Almeida, Gisele Caravina, Viana-Pereira, Marta, Cruvinel-Carloni, Adriana, Spina, Maria Luisa, Campanella, Nathalia Cristina, Pereira de Menezes, Weder, Clara, Carlos Afonso, Becker, Aline Paixão, Jones, Chris, Reis, Rui Manuel

Volltext

Immunogenicity, Including Vitiligo, and Feasibility of Vaccination With Autologous GM-CSF–Transduced Tumor Cells in Metastatic Melanoma Patients von LUITEN, Rosalie M, KUETER, Esther W. M, SEIN, Johan, VAN DEN BERK, Paul C. M, NIEWEG, Omgo E, BERNS, Anton M, SPITS, Hereen, DE GAST, Giisbert C, MOOI, Walter, GALLEE, Maarten P. W, RANKIN, Elaine M, GERRITSEN, Winald R, CLIFT, Shirley M, NOOIJEN, Willem J, WEDER, Pauline, VAN DE KASTEELE, Willeke F

Volltext

Abstract P5-14-05: Phase 1 evaluation of the androgen receptor modulator CR1447 in patients with advanced breast cancer (SAKK 21/12) von Schoenfeld, W, Zweifel, M, Thuerlimann, B, Riniker, S, Weder, P, von Moos, R, Pagani, O, Bigler, M, Rothgiesser, KM, Pilop, C, Brauchli, P, Tapia, C, Sessa, C

Volltext

Abstract OT1-1-05: Pernetta: A randomized phase II trial of pertuzumab + trastuzumab with or without chemotherapy, both followed by T-DM1 at progression, in patients with HER2-posi... von Huober, J, Weder, P, Boven, E, Oehlschlegel, C, Mac Grogan, G, Thuerlimann, B, Li, Q, Hawle, H, Brauchli, P, Ribi, K, Gerard, M-A, Lemonnier, J, van Giesen, J, Bonnefoi, H

Volltext